Oct 1, 2018 PharmaCyte Biotech Reports Completion of Crucial FDA-Required Study for Pancreatic Cancer Trial
Sep 27, 2018 PharmaCyte Biotech Successfully Completes Comparative Analysis of Methods for Measuring Viability of Encapsulated Cells
Sep 18, 2018 PharmaCyte Biotech Successfully Completes Final Pre-Production Run of Pancreatic Cancer Product
Jul 23, 2018 PharmaCyte Biotech Successfully Completes Another Study on the Encapsulated Cells Used in Its Pancreatic Cancer Therapy
Jun 28, 2018 PharmaCyte Biotech Discusses Importance of Shrinking Pancreatic Cancer Tumors in Latest Q&A Series
Jun 14, 2018 PharmaCyte Biotech Successfully Completes Another FDA Required Study Necessary for Submitting Investigational New Drug Application
Jun 1, 2018 PharmaCyte Biotech Receives Certificates of Analysis from Eurofins on Cells Used for Pancreatic Cancer Therapy
May 30, 2018 PharmaCyte Biotech CEO and CSO Interviewed About IND, Planned Clinical Trial in Pancreatic Cancer, CRO and More
May 16, 2018 PharmaCyte Biotech Successfully Completes 29 Tests Conducted on Live Cells Used in Pancreatic Cancer Therapy
May 9, 2018 PharmaCyte Biotech Successfully Completes Pore Size Studies in Cell-in-a-Box® Capsules Used in Pancreatic Cancer Therapy
